Table 1 Baseline characteristics of randomized patients
IFX (N=20) | TRIPLE (N=20) | MTX (N=20) | |
|---|---|---|---|
Female, n (%) | 14 (70) | 14 (70) | 11 (55) |
Age (years) mean (SD) | 10.5 (3.2) | 8.3 (2.7) | 9.6 (3.2) |
Age of onset of JIA, years | 10.5 (3.1) | 8.1 (2.7) | 10.0 (3.5) |
ANAAb positive, n (%) | 9 (47) | 7 (35) | 6 (30) |
ESR, mm/h, mean (SD) | 28 (20) | 41 (33) | 39 (30) |
JADAS-10 | 17.1 (4.4) | 20.1 (5.0) | 21.9 (5.4) |
Active joint count, mean (SD) | 18 (10) | 17 (10) | 18 (12) |
Physician VAS, mean (SD) | 49 (18) | 55 (19) | 60 (18) |
CHAQ | 0.49 (0.6) | 0.71 (0.6) | 1.07 (0.6) |
EQ-5D a | |||
Roche quadratic | 0.73 (0.14) | 0.78 (0.16) | 0.60 (0.15) |
NICE quadratic | 0.68 (0.15) | 0.62 (0.18) | 0.52 (0.18) |
Roche linear | 0.75 (0.15) | 0.69 (0.18) | 0.59 (0.17) |
Boggs et al. linear | 0.66 (0.16) | 0.60 (0.18) | 0.49 (0.18) |